Sfoglia per AUTORE
PARVIS G
Collezione AOU San Luigi di Orbassano

  

Items : 18

The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial. in Cancer medicine / Cancer Med. 2020 Dec;9(23):8735-8746. doi: 10.1002/cam4.3396. Epub 2020 Nov 6.

2020
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino

Gallamini A; Rambaldi A; Massimo Gianni A; Chauvie S; Biggi A; Ferreri AJM; Viero P; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Zoli V; Gavarotti P; Bolis S; Trentin L; La Nasa G; Cantonetti M; Picardi M; Rossi A; Patti C; Viviani S; Tarella C; Di Raimondo F; Pavoni C; Romano A;

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial. in Haematologica / Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Ladetto M; Tarella C; Corradini P; Passera R; Gianni AM; Billio A; Gueli A; Mantoan B; Rambaldi A; Angrilli F; Perrone T; Lanza F; Parvis G; Semenzato G; Dondi A; Zallio F; Narni F; Devizzi L; Zoli V; Tucci A; Di Raimondo F; Stelitano C; Rota-Scalabrini D; Ciceri F; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; et alii...

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Gianni AM; Pavoni C; Chauvie S; Bergesio F; Prosperini G; Chiaravalloti A; Gregianin M; Ficola U; Fallanca F; Biggi A; Avigdor A; Billio A; Miglino M; Viero P; Ferreri AJM; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Gavarotti P; Gottardi D; Battistini R; Rapezzi D; Bolis S; Trentin L; La Nasa G; et alii...

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. in Oncotarget / Oncotarget. 2017 May 30;8(22):35508-35522. doi: 10.18632/oncotarget.16348.

2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Carrà G; Panuzzo C; Torti D; Parvis G; Crivellaro S; Familiari U; Volante M; Morena D; Lingua MF; Brancaccio M; Guerrasio A; Pandolfi PP; Saglio G; Taulli R; Morotti A;

Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2017 Jan;17(1):14-22. doi: 10.1016/j.clml.2016.09.008. Epub 2016 Sep 17.

2017
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Gottardi D; Parvis G; Freilone R; Nicolosi M; Pregno P; Gavarotti P; Botto B; Filippi AR; Piva C; Levis M; Vitolo U; Ricardi U;

Diffusion-weighted quantitative MRI to diagnose benign conditions from malignancies of the anterior mediastinum: Improvement of diagnostic accuracy by comparing perfusion-free to perfusion-sensitive measurements of the apparent diffusion coefficient. in Journal of magnetic resonance imaging : JMRI / J Magn Reson Imaging. 2016 Sep;44(3):758-69. doi: 10.1002/jmri.25203. Epub 2016 Feb 19.

2016
AOU San Luigi di Orbassano

Priola AM; Priola SM; Gned D; Piacibello E; Sardo D; Parvis G; Torti D; Ardissone F; Veltri A;

Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study. in International journal of radiation oncology, biology, physics / Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):783-91. doi: 10.1016/j.ijrobp.2015.12.019. Epub 2015

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L;

Usefulness of diffusion-weighted magnetic resonance imaging for assessing early treatment response in lymphoma patients. in Acta radiologica (Stockholm, Sweden : 1987) / Acta Radiol. 2015 Feb;56(2):NP10-1. doi: 10.1177/0284185114554254. Epub 2014 Oct 20.

2015
AOU San Luigi di Orbassano

Priola AM; Gned D; Parvis G; Torti D; Priola SM;

Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2013 Sep 20;31(27):3351-9. doi: 10.1200/JCO.2012.44.8290. Epub 2013 Aug 19.

2013
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Vitolo U; Ladetto M; Boccomini C; Baldini L; De Angelis F; Tucci A; Botto B; Chiappella A; Chiarenza A; Pinto A; De Renzo A; Zaja F; Castellino C; Bari A; Alvarez De Celis I; Evangelista A; Parvis G; Gamba E; Lobetti-Bodoni C; Ciccone G; Rossi G;

Intensified chemo-immunotherapy including up-front autologous or allogeneic stem cell transplantation (SCT) for young patients with newly diagnosed peripheral T-cell lymphomas: Final results of a phase II multicenter prospective clinical trial in Blood

2012
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Corradini P; Vitolo U; Rambaldi A; Miceli R; Patriarca F; Gallamini A; Olivieri A; Benedetti F; Todeschini G; Rossi G; Parvis G; Salvi F; Bruno B; Baldini L; Patti C; Milone G; Ferreri AJM; Tarella C; Pileri SA; Dodero A;

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.

2011
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Benedetti F; Rossi A; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Zoli V; Corradini P; Carobbio A; Mulé A; Bosa M; Barbui A; Di Nicola M; Sorio M; Caracciolo D; Gianni AM; Rambaldi A;

Rituximab followed by involved fields radiotherapy (IF-RT) in stage I-II follicular lymphoma (FL): Long term results in Blood

2011
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ruella M; Filippi A; Russo ADI; Caracciolo D; Matteucci P; Magni M; Di Nicola M; Ricardi U; Montefusco V; Parvis G; Tarella C; Gianni AM; Devizzi L;

Male gender, quality of grafted cells, advanced age, rituximab and radiotherapy are the main factors that variously influence the occurrence of secondary malignancies following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) survey in 1,347 lymphoma patients in Blood

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Benedetti F; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Mule A; Crocchiolo R; Bosa M; Barbui A; Di Nicola M; Caracciolo D; Sorio M; Gianni AM; Rambaldi A;

Factors influencing the occurrence of secondary myelodysplastic syndrome/acute leukemia following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie innovative nei linfomi) survey in 1,347 lymphoma patients in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Gueli A; Benedetti F; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Leone M; Bosa M; Barbui A; Di Nicola M; Boccadoro M; Sorio M; Gianni AM; Rambaldi A;

Limited stage low-grade lymphoma patients receiving Rituximab combined with localized radiotherapy: The long-term follow-up shows prolonged survival with low incidence of disease recurrence in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Caracciolo D; Ruella M; Bazzan M; Parvis G; Ladetto M; Boccadoro M; Mistretta A; Patti C; Todisco L; Franco P; Ricardi U; Filippi AR;

Histology and rituximab addition are the main factors influencing the long-term outcome in high-risk lymphoma following high-dose therapy and autograft: A 20-yr. Follow-up in 1,347 patients by gitil (gruppo italiano terapie innovative NEI Linfomi) in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Di Nicola M; Rossi A; Caracciolo D; Passera R; Benedetti F; Patti C; Parvis G; Ciceri F; Castellino C; Cortelazzo S; Corradini P; Majolino I; Mule' A; Bosa M; Barbui A; Magni M; Boccadoro M; Sorio M; Rambaldi A; Gianni AM;

Follow-up of mediastinal lymphoma: role of ultrasonography. in La Radiologia medica / Radiol Med. 2006 Sep;111(6):759-72. doi: 10.1007/s11547-006-0070-z. Epub 2006 Aug 11.

2006
AOU San Luigi di Orbassano

De Pascale A; Giorcelli R; Garofalo G; Perotto F; Parvis G; Gino M; Fava C;

CT findings in primary pulmonary lymphomas. in La Radiologia medica / Radiol Med. 2005 Nov-Dec;110(5-6):554-60.

2005
AOU San Luigi di Orbassano

Cardinale L; Allasia M; Cataldi A; Ferraris F; Parvis G; Fava C;